Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
ADCY5 protein results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | increases response to substance | 12223546
|
C061282 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine |
ADCY5 protein results in increased susceptibility to [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine co-treated with Quinpirole] | affects cotreatment|increases response to substance | 12223546
|
D002118 |
Calcium |
Calcium results in decreased activity of ADCY5 protein | decreases activity | 12065575
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [Forskolin results in increased activity of ADCY5 protein] | decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY5 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine results in decreased activity of ADCY5 protein | decreases activity | 19922557
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in increased expression of ADCY5 mRNA | affects cotreatment|increases expression | 18636392
|
D003024 |
Clozapine |
ADCY5 protein affects the susceptibility to Clozapine | affects response to substance | 12223546
|
D003024 |
Clozapine |
SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Clozapine] | affects response to substance|decreases reaction | 12223546
|
C061532 |
dihydrexidine |
ADCY5 protein results in increased susceptibility to dihydrexidine | increases response to substance | 12223546
|
C061532 |
dihydrexidine |
ADCY5 protein results in increased susceptibility to [dihydrexidine co-treated with Quinpirole] | affects cotreatment|increases response to substance | 12223546
|
D005557 |
Formaldehyde |
Formaldehyde results in decreased expression of ADCY5 mRNA | decreases expression | 14756816
|
D005576 |
Forskolin |
ADCY5 protein results in increased susceptibility to [Forskolin co-treated with Quinpirole] | affects cotreatment|increases response to substance | 12223546
|
D005576 |
Forskolin |
Carbamazepine inhibits the reaction [Forskolin results in increased activity of ADCY5 protein] | decreases reaction|increases activity | 19922557
|
D005576 |
Forskolin |
Forskolin results in increased activity of ADCY5 protein | increases activity | 19922557
|
D006220 |
Haloperidol |
ADCY5 protein affects the susceptibility to Haloperidol | affects response to substance | 12223546
|
D006220 |
Haloperidol |
SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Haloperidol] | affects response to substance|decreases reaction | 12223546
|
D008094 |
Lithium |
Lithium results in decreased activity of ADCY5 protein | decreases activity | 19922557
|
D008094 |
Lithium |
Magnesium inhibits the reaction [Lithium results in decreased activity of ADCY5 protein] | decreases activity|decreases reaction | 19922557
|
D008274 |
Magnesium |
Magnesium results in increased activity of ADCY5 protein | increases activity | 12065575
|
D008274 |
Magnesium |
Magnesium inhibits the reaction [Lithium results in decreased activity of ADCY5 protein] | decreases activity|decreases reaction | 19922557
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in increased expression of ADCY5 mRNA | affects cotreatment|increases expression | 18636392
|
D010269 |
Paraquat |
Paraquat results in increased expression of ADCY5 mRNA | increases expression | 17077588
|
D019257 |
Quinpirole |
ADCY5 protein results in increased susceptibility to [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine co-treated with Quinpirole] | affects cotreatment|increases response to substance | 12223546
|
D019257 |
Quinpirole |
ADCY5 protein results in increased susceptibility to [dihydrexidine co-treated with Quinpirole] | affects cotreatment|increases response to substance | 12223546
|
D019257 |
Quinpirole |
ADCY5 protein results in increased susceptibility to [Forskolin co-treated with Quinpirole] | affects cotreatment|increases response to substance | 12223546
|
D019257 |
Quinpirole |
ADCY5 protein results in increased susceptibility to [Quinpirole co-treated with VIP protein] | affects cotreatment|increases response to substance | 12223546
|
C534628 |
SCH 23390 |
SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Clozapine] | affects response to substance|decreases reaction | 12223546
|
C534628 |
SCH 23390 |
SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Haloperidol] | affects response to substance|decreases reaction | 12223546
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY5 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY5 protein | affects binding|increases activity | 19922557
|
D013469 |
Sulpiride |
ADCY5 protein results in increased susceptibility to Sulpiride | increases response to substance | 12223546
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ADCY5 mRNA | decreases expression | 19933214
|
D015647 |
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
ADCY5 protein results in increased susceptibility to 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | increases response to substance | 12223546
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
8.50 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.50 | 11752688 15322242 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
4.26 | 20601635 |
MESH:D000236 |
Adenoma |
|
Magnesium |
4.51 | 17823441 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.32 | 16835633 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
4.99 | 14617031 16160616 12649775 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.70 | 11874814 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
4.66 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.66 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.89 | 11748828 |
MESH:D000855 |
Anorexia |
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
11.07 | 12183048 |
MESH:D000855 |
Anorexia |
|
Quinpirole |
11.07 | 12183048 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.54 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.62 | 16373670 17854713 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.92 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
Magnesium |
2.92 | 16846101 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
7.90 | 20046352 17594078 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
7.90 | 20338123 20046352 17594078 19153942 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.98 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.73 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.72 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Formaldehyde |
2.65 | 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.65 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.62 | 16777450 19059883 18417511 18315731 15516495 14754758 17626835 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.68 | 16183385 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.74 | 16835633 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.33 | 18850075 18670907 16120746 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.85 | 1977408 15215559 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.10 | 16835633 |
MESH:D016770 |
Ciliophora Infections |
|
Formaldehyde |
5.59 | 12113305 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.08 | 8697196 15668235 15340226 12621046 16354765 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
4.90 | 17123785 |
MESH:D003111 |
Colonic Polyps |
|
Magnesium |
5.99 | 17823441 |
MESH:D015179 |
Colorectal Neoplasms |
|
Magnesium |
3.45 | 17823441 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.00 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
2.84 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 10048152 20055451 15322242 |
MESH:D007644 |
Darier Disease |
|
Lithium |
5.85 | 20338123 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.78 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.52 | 11575062 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Formaldehyde |
4.65 | 15059100 16958921 15932584 12081698 14996049 |
MESH:D002658 |
Developmental Disabilities |
|
Magnesium |
4.86 | 16846101 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.68 | 19244398 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
marker/mechanism |
|
| 20081858 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.45 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.45 | 17107852 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.50 | 15331141 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
5.38 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.37 | 16538175 20216337 16538176 15057820 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
4.10 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.10 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
8.23 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.23 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.13 | 16402076 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
4.57 | 20016425 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.32 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.85 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
4.67 | 17654737 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.96 | 10568697 9294722 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
5.19 | 16415921 16538176 20485159 18855540 19915237 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
5.15 | 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
4.92 | 17116037 16628512 15008574 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
3.96 | 17178248 17465707 18234410 821787 7988514 19620853 20417680 19700373 9014606 19439326 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
5.29 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
5.06 | 15276670 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.66 | 19549232 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
5.41 | 20485159 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 11564622 |
MESH:D005141 |
Eyelid Diseases |
|
Formaldehyde |
6.32 | 14996049 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.39 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.89 | 20067830 |
MESH:D005393 |
Fish Diseases |
|
Formaldehyde |
5.55 | 12113305 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.95 | 20016425 |
MESH:D005911 |
Gliosis |
|
Paraquat |
5.11 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.54 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
6.91 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.91 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.27 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.83 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.99 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.67 | 10459572 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
12.07 | 16046005 |
MESH:D006948 |
Hyperkinesis |
|
dihydrexidine |
12.07 | 14960337 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
5.15 | 18773962 |
MESH:D006973 |
Hypertension |
marker/mechanism |
|
| 12717102 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.88 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
3.21 | 4850670 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.82 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 16580747 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.99 | 16316344 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
3.91 | 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.69 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.07 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.33 | 19066396 8266340 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.78 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
2.36 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.36 | 11884234 19555203 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.55 | 16628512 |
MESH:D008275 |
Magnesium Deficiency |
|
Magnesium |
6.38 | 17823441 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
13.22 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
13.22 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Sulpiride |
13.22 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.70 | 9014606 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.35 | 19142101 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.05 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Magnesium |
4.72 | 18803445 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
3.90 | 16288908 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.96 | 12213967 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
5.41 | 20399394 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.66 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
9.71 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.71 | 14600291 |
MESH:D009669 |
Nose Neoplasms |
|
Formaldehyde |
5.28 | 4038687 |
MESH:D009765 |
Obesity |
|
Clozapine |
3.00 | 18515891 19142110 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
5.41 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.74 | 17882678 |
MESH:D010146 |
Pain |
|
Carbamazepine |
3.98 | 15215642 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.64 | 16538176 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.79 | 16140633 16510128 15824117 15451049 11445065 12911755 11181820 11124998 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
4.37 | 16190885 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
5.86 | 17679678 17145499 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.19 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.07 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
10.86 | 18007984 18929643 18381685 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
10.86 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.49 | 18163543 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
5.09 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
9.65 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.65 | 11896295 11399792 11118676 11222880 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
5.54 | 12752131 9591791 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
4.89 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.00 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.00 | 11575062 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
2.89 | 17997886 16324872 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
5.16 | 18579056 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
3.84 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.99 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.82 | 16458197 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
4.06 | 20168265 19369910 17667964 20521320 20452607 11763009 18855531 18806925 20107430 11151749 17726453 17123785 20580759 20521326 16141801 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
4.06 | 1830565 20107430 19369910 18513383 |
MESH:D012595 |
Scleroderma, Systemic |
|
Formaldehyde |
5.80 | 14979077 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
6.71 | 9844417 16180713 9046859 16938433 16876388 19414003 15946322 |
MESH:D012640 |
Seizures |
|
Lithium |
6.71 | 19660546 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
5.06 | 19414003 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
5.73 | 19430551 19951488 19570321 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
5.15 | 16538176 19915237 16415921 18855540 20485159 19694795 15057820 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.64 | 20210726 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.85 | 12697716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.54 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.19 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.41 | 20521320 16141801 20564506 17502770 16402076 20107430 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.02 | 17933447 |